Coghill, David R.
Banaschewski, Tobias
Nagy, Peter
Otero, Isabel Hernández
Soutullo, César
Yan, Brian
Caballero, Beatriz
Zuddas, Alessandro
Funding for this research was provided by:
Shire Development LLC
Shire International GmbH
Article History
First Online: 30 June 2017
Compliance with Ethical Standards
:
: The study was funded by Shire Development LLC. Writing and editing assistance for this paper was funded by Shire International GmbH. Shire International GmbH also funded open access.
: BC and BY are employees of Shire and own stock or stock options. The following authors have received compensation for serving as consultants or speakers for, or they or the institutions they work for have received research support or royalties from, the companies or organizations indicated: TB (Actelion, Hexal Pharma, Lilly, Medice, Novartis, Otsuka, Shire, and Vifor Pharma); DRC (Eli Lilly, Janssen-Cilag, Medice, Novartis, Oxford University Press, Shire, and Vifor Pharma); PN (Lilly, Otsuka, and Shire); IHO (Alicia Koplowitz Foundation, Eli Lilly, Forest, Janssen-Cilag, Junta de Andalucía, Roche, Shire, Shire Pharmaceuticals Iberica S.L., and Sunovion); CAS (Alicia Koplowitz Foundation, Editorial Médica Panamericana, Eli Lilly, EUNSA [University of Navarra Press], Fundación Caja Navarra, Janssen, Mayo Eds, Medice/Juste, NeuroTech Solutions, Rubiò, Shire, Sociedad Vasco-Navarra de Psiquiatría, University of Navarra Research Projects [PIUNA], and Wolters Kluwer); AZ (Angelini, EduPharma, Lilly, Lundbeck, Otsuka, Oxford University Press, Roche, Shire, Takeda and Vifor Pharma).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Each patient’s parent/legal guardian provided written, informed consent, and assent was obtained from each participant (as applicable) before they took part in the study.